MEDICLIN announced preliminary consolidated earnings results for 2017. For the year, the company's reported group sales of EUR 609.1 million compared to EUR 580.3 million for the same period a year ago. Preliminary group EBIT was EUR 6.6 million compared to EUR 24.0 million for the same period a year ago. Total consolidated results attributable to shareholders was EUR 3.9 million or EUR 0.08 preliminary earnings per share compared to EUR 16.6 million or EUR 0.35 preliminary earnings per share for the same period a year ago. Net financial debt amounts to EUR 20.6 million. For the year EUR 46.8 million compared to EUR 28.1 million were invested in non-current assets for the same period a year ago. For the year, the company's spent EUR 17.6 million compared to EUR 18.5 million on maintenance and repair for the same period a year ago. Preliminary Group EBIT includes a one-off provision of EUR 20.1 million for a debtor warrant. Without the provision, the preliminary Group EBIT would be EUR 26.7 million and the preliminary Group result EUR 20.9 million.